1. International Agency for Research on Cancer. Stomach cancer incidence, mortality and prevalence worldwide in 2008 summary. http://globacan.iarc.fr . Accessed 10 July 2012.
2. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: gastric cancer guideline 2011 (Chinese). http://www.nccnchina.org.cn/nccn-guidelines-china.aspx . Accessed 10 July 2012.
3. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: gastric cancer guideline 2010 (Chinese). http://wenku.baidu.com/view/119d92e819e8b8f67c1cb91b.html . Accessed 10 July 2012.
4. Bang Y-J, Kim Y-W, Yang H-K, et al. Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial. Lancet. 2012;379:315–21.
5. National Bureau of Statistics of the People’s Republic of China. Gross domestic product. http://www.stats.gov.cn/tjsj/ndsj/2011/html/C0201e.htm . Accessed 6 July 2012.